{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:22:50Z","timestamp":1790875370248,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872352, 82002525"],"award-info":[{"award-number":["81872352, 82002525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recent studies have confirmed that AT-rich interactive domain-containing protein 1A (ARID1A) plays a critical role in tumorigenesis, but its role in gallbladder cancer (GBC) remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 224 patients from Zhongshan Hospital were recruited for this retrospective study. The clinicopathological and baseline characteristics of the patients were collected. Bioinformatics analysis was performed to reveal variations in genes and signaling pathways, and ARID1A and PD-L1 expression and the number of PD1+ tumor-infiltrating lymphocytes (TILs) were measured by immunohistochemical staining.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>ARID1A expression was negatively correlated with overall survival in patients with GBC, and multivariate analysis identified ARID1A as an independent prognostic factor for overall survival. A heatmap and gene set enrichment analysis suggested that cytotoxic T lymphocyte signatures and immune-related signaling pathways were downregulated in ARID1A low tumors. Subsequent immunohistochemical staining confirmed that ARID1A expression was negatively correlated with PD-L1 expression and PD1+ TILs in the tumor microenvironment. The Kaplan\u2013Meier analysis suggested that high ARID1A expression combined with low PD-L1 expression or low PD1+ TIL counts is associated with the best prognosis in patients with GBC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ARID1A inactivation can lead to a worse prognosis in patients with GBC, potentially by mediating immune evasion through the PD1\/PD-L1 pathway.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.787897","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T05:23:55Z","timestamp":1644211435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["ARID1A Downregulation Predicts High PD-L1 Expression and Worse Clinical Outcome in Patients With Gallbladder Cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Lingxi","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.02.010","article-title":"Carcinoma of the Gallbladder: Patterns of Presentation, Prognostic Factors and Survival Rate. An 11-Year Single Centre Experience","volume":"39","author":"D\u2019Hondt","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"B2","volume-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3958","article-title":"SMARCB1 Is Required for Widespread BAF Complex-Mediated Activation of Enhancers and Bivalent Promoters","volume":"49","author":"Nakayama","year":"2017","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.26","article-title":"Mechanisms of Action and Regulation of ATP-Dependent Chromatin-Remodelling Complexes","volume":"18","author":"Clapier","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and Bioinformatic Analysis of Mammalian SWI\/SNF Complexes Identifies Extensive Roles in Human Malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and Saturation Analysis of Cancer Genes Across 21 Tumour Types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh277","article-title":"The DNA-Binding Properties of the ARID-Containing Subunits of Yeast and Mammalian SWI\/SNF Complexes","volume":"32","author":"Wilsker","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ccell.2017.10.007","article-title":"Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer","volume":"32","author":"Sun","year":"2017","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0300-6","article-title":"ARID1A Mutation Sensitizes Most Ovarian Clear Cell Carcinomas to BET Inhibitors","volume":"37","author":"Berns","year":"2018","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.07.022","article-title":"Therapeutic Relevance of Targeted Sequencing in Management of Patients With Advanced Biliary Tract Cancer: DNA Damage Repair Gene Mutations as a Predictive Biomarker","volume":"120","author":"Chae","year":"2019","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30254","article-title":"Biliary Cancer: Utility of Next-Generation Sequencing for Clinical Management","volume":"122","author":"Javle","year":"2016","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9602-8","article-title":"Genomics of Gallbladder Cancer: The Case for Biomarker-Driven Clinical Trial Design","volume":"35","author":"Sicklick","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic Characterization of Biliary Tract Cancers Identifies Driver Genes and Predisposing Mutations","volume":"68","author":"Wardell","year":"2018","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-020-00718-5","article-title":"Multigene Mutational Profiling of Biliary Tract Cancer Is Related to the Pattern of Recurrence in Surgically Resected Patients","volume":"72","author":"Conci","year":"2020","journal-title":"Updates Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw071","article-title":"Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas","volume":"145","author":"Sasaki","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.1038\/s41598-019-43293-5","article-title":"Prognostic Role of ARID1A Negative Expression in Gastric Cancer","volume":"9","author":"Ashizawa","year":"2019","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/cells8070678","article-title":"ARID1A Mutations Are Associated With Increased Immune Activity in Gastrointestinal Cancer","volume":"8","author":"Li","year":"2019","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for First-Line Treatment of PD-L1-Selected Patients With NSCLC","volume":"383","author":"Herbst","year":"2020","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R111.309302","article-title":"SWI\/SNF Chromatin-Remodeling Factors: Multiscale Analyses and Diverse Functions","volume":"287","author":"Euskirchen","year":"2012","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/his.14096","article-title":"Loss of Switch\/Sucrose Non-Fermenting Complex Protein Expression in Undifferentiated Gastrointestinal and Pancreatic Carcinomas","volume":"77","author":"Tessier-Cloutier","year":"2020","journal-title":"Histopathology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1042\/CS20200244","article-title":"Enhanced SMARCD1, a Subunit of the SWI\/SNF Complex, Promotes Liver Cancer Growth Through the mTOR Pathway","volume":"134","author":"Zhou","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0541-5","article-title":"ARID1A Influences HDAC1\/BRD4 Activity, Intrinsic Proliferative Capacity and Breast Cancer Treatment Response","volume":"52","author":"Nagarajan","year":"2020","journal-title":"Nat Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315490","article-title":"SWI\/SNF Component ARID1A Restrains Pancreatic Neoplasia Formation","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"key":"B24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13046-015-0164-3","article-title":"Decreased Expression of ARID1A Associates With Poor Prognosis and Promotes Metastases of Hepatocellular Carcinoma","volume":"34","author":"He","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/his.12566","article-title":"Loss of ARID1A Expression is Associated With Poor Prognosis in Small Intestinal Carcinoma","volume":"66","author":"Kim","year":"2015","journal-title":"Histopathology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"28919","DOI":"10.1038\/srep28919","article-title":"Loss of ARID1A Expression Predicts Poor Survival Prognosis in Gastric Cancer: A Systematic Meta-Analysis From 14 Studies","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgz179","article-title":"Loss of ARID1A Induces a Stemness Gene ALDH1A1 Expression With Histone Acetylation in the Malignant Subtype of Cholangiocarcinoma","volume":"41","author":"Yoshino","year":"2019","journal-title":"Carcinogenesis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900959","article-title":"ARID1a Associates With Lymphoid-Restricted Transcription Factors and Has an Essential Role in T Cell Development","volume":"205","author":"Astori","year":"2020","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2404","article-title":"ARID1A Mutation May Define an Immunologically Active Subgroup in Patients With Microsatellite Stable Colorectal Cancer","volume":"27","author":"Mehrvarz Sarshekeh","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10020-020-00208-9","article-title":"Subunits of ARID1 Serve as Novel Biomarkers for the Sensitivity to Immune Checkpoint Inhibitors and Prognosis of Advanced Non-Small Cell Lung Cancer","volume":"26","author":"Sun","year":"2020","journal-title":"Mol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.21037\/atm-20-922","article-title":"Identification of Molecular Features Correlating With Tumor Immunity in Gastric Cancer by Multi-Omics Data Analysis","volume":"8","author":"He","year":"2020","journal-title":"Ann Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0243","article-title":"Comprehensive Analysis of Multiple Parameters Associated With Tumor Immune Microenvironment in ARID1A Mutant Cancers","volume":"16","author":"Li","year":"2020","journal-title":"Future Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lungcan.2019.10.009","article-title":"Non-Small Cell Lung Cancer With Loss of Expression of the SWI\/SNF Complex Is Associated With Aggressive Clinicopathological Features, PD-L1-Positive Status, and High Tumor Mutation Burden","volume":"138","author":"Naito","year":"2019","journal-title":"Lung Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32140","article-title":"Functional Loss of ARID1A Is Tightly Associated With High PD-L1 Expression in Gastric Cancer","volume":"145","author":"Kim","year":"2019","journal-title":"Int J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.07.005","article-title":"ARID1A Mutation\/ARID1A Loss Is Associated With a High Immunogenic Profile in Clear Cell Ovarian Cancer","volume":"162","author":"Kuroda","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.09.006","article-title":"The Impact of ARID1A Mutation on Molecular Characteristics in Colorectal Cancer","volume":"140","author":"Tokunaga","year":"2020","journal-title":"Eur J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1659","article-title":"ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma","volume":"5","author":"Iseda","year":"2021","journal-title":"Hepatol Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000438","article-title":"ARID1A Alterations Function as a Biomarker for Longer Progression-Free Survival After Anti-PD-1\/PD-L1 Immunotherapy","volume":"8","author":"Okamura","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1302","article-title":"HDAC6 Inhibition Synergizes With Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer","volume":"79","author":"Fukumoto","year":"2019","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.01.001","article-title":"ARID1A Deficiency and Immune Checkpoint Blockade Therapy: From Mechanisms to Clinical Application","volume":"473","author":"Hu","year":"2020","journal-title":"Cancer Lett"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.787897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T05:24:01Z","timestamp":1644211441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.787897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":40,"alternative-id":["10.3389\/fonc.2022.787897"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.787897","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"article-number":"787897"}}